Corticosteroid-induced aseptic necrosis. II. Experimental study.
D000818:Animals; D001847:Bone Diseases / Q000139:chemically induced* / Q000473:pathology; D002784:Cholesterol / Q000097:blood; D004620:Embolism, Fat / Q000139:chemically induced / Q000473:pathology; D005234:Fatty Liver / Q000139:chemically induced / Q000473:pathology; D005270:Femur Head / Q000473:pathology; D005938:Glucocorticoids / Q000009:adverse effects*; D006811:Humerus / Q000473:pathology; D007275:Injections, Intravenous; D007668:Kidney / Q000473:pathology; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D009336:Necrosis; D010743:Phospholipids / Q000097:blood; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000473:pathology; D011817:Rabbits; D014280:Triglycerides / Q000097:blood
D005938:Glucocorticoids; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol; D008775:Methylprednisolone